Dr. John Schrolucke, Optometrist Optometrist Medicare: Not Enrolled in Medicare Practice Location: 25 W Yavapai St, Wickenburg, AZ 85390 Phone: 928-684-2880 Fax: 928-684-3209 |
News Archive
Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could — paradoxically — shorten treatment time for the highly contagious lung infection according to new research from Johns Hopkins Children's Center and the Center for TB Research.
Fatal bleeding is rare with extended dual antiplatelet therapy, according to a secondary analysis of the DAPT Study presented for the first time today at ESC Congress. Bleeding-related mortality accounted for a minority of deaths in patients treated with dual antiplatelet therapy beyond one year.
A variety of measures are necessary to prevent the spread of the coronavirus SARS-CoV-2 in hospitals and nursing homes. It is particularly important to develop an appropriate strategy to protect healthcare workers from airborne transmission.
In a study that included more than 56,000 patients with inflammatory bowel disease, use of a popular class of medications known as tumor necrosis factor alpha antagonists was not associated with an increased risk of cancer over a median follow-up of 3.7 years, although an increased risk of malignancy in the long term, or with increasing number of doses, cannot be excluded, according to a study in the June 18 issue of JAMA.
Researchers at the Georgia Institute of Technology have developed a material that may one day allow patients to forgo daily injections and pills and receive prescriptions instead through micro-thin implantable films that release medication according to changes in temperature.
› Verified 3 days ago